Emerging and Healthcare Associated Infections: Surveillance and Prevention
The Emerging Infections Program (EIP) is part of a national effort to provide population-based communicable disease data for surveillance of disease patterns, evaluation of vaccine programs, and to identify populations at risk for severe infection and those in need of screening and preventive care. EIP projects include studies of risk factors for influenza disease requiring hospital admission, methicillin-resistant Staphylococcus aureus (MRSA), and Clostridium difficile in healthcare and community settings. The Healthcare Associated Infections Collaborative develops quality assessment methods to monitor central line-associated blood stream infections outside the ICU and related projects. Work in the Center for Community Health’s EIP-HAI group serves as a foundation for research studies and informs public health practice and policy at the local, state and national levels.
Emerging Infections Programs:- Clostridium difficile
- Influenza
- MRSA: methicillin-resistant Staphylococcus aureus (MRSA) JAMA 2010
- Invasive S. pneumoniae disease (Invasive Pneumococcal disease 12 year Summary)
- HPV Impact: Impact of Human Papilloma Virus Vaccine on incidence of CIN 2,3, and AIS in women aged > 18 years
- HAI: Health Care Associated Infections
HAI Prevention Collaborative
- CLABSI: Central Line Associated Blood Stream Infections Outside the ICU CLABSI education module; September 15th Workshop at the MAG presentations
Other Prevention Programs
- MCSkipp: Monroe County School Kids Influenza Prevention Project
Contact the Emerging and Healthcare Associated Infections Group at 585-224-3075
